Technical Analysis for PTI - Proteostasis Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 0.73 0.00% 0.00
PTI closed unchanged on Friday, October 18, 2019, on 66 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical PTI trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Volume Surge Other 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -0.54%
Oversold Stochastic Weakness -0.54%
50 DMA Resistance Bearish -5.19%

Older signals for PTI ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Proteostasis Therapeutics, Inc., a biopharmaceutical company, develops therapeutics to treat protein conformational diseases. The company offers disease-modifying therapeutics for cystic fibrosis; and also develops treatments for diseases caused by an imbalance in the proteostasis network and characterized by defects in protein folding, trafficking, and clearance, including genetic, neurodegenerative, and retinal degenerative diseases. Its lead product candidate is PTI-428, an orally bioavailable cystic fibrosis transmembrane conductance regulator modulator belonging to the amplifier class. The company was formerly known as Proteoguard, Inc. and changed its name to Proteostasis Therapeutics, Inc. in September 2007. The company was founded in 2006 and is based in Cambridge, Massachusetts.
Biopharmaceutical Biology Diseases Cystic Fibrosis Proteins Proteomics Protein Folding
Is PTI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.47
52 Week Low 0.61
Average Volume 393,048
200-Day Moving Average 1.7077
50-Day Moving Average 0.7993
20-Day Moving Average 0.8244
10-Day Moving Average 0.7734
Average True Range 0.0611
ADX 22.6
+DI 11.8074
-DI 19.3393
Chandelier Exit (Long, 3 ATRs ) 0.8267
Chandelier Exit (Short, 3 ATRs ) 0.8966
Upper Bollinger Band 0.9654
Lower Bollinger Band 0.6834
Percent B (%b) 0.17
BandWidth 34.206696
MACD Line -0.031
MACD Signal Line -0.0173
MACD Histogram -0.0137
Fundamentals Value
Market Cap 18.32 Million
Num Shares 25.1 Million
EPS -2.19
Price-to-Earnings (P/E) Ratio -0.33
Price-to-Sales 6.19
Price-to-Book 0.96
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.78
Resistance 3 (R3) 0.78 0.77 0.77
Resistance 2 (R2) 0.77 0.75 0.77 0.77
Resistance 1 (R1) 0.75 0.74 0.74 0.75 0.77
Pivot Point 0.73 0.73 0.73 0.73 0.73
Support 1 (S1) 0.71 0.72 0.70 0.71 0.69
Support 2 (S2) 0.70 0.71 0.69 0.69
Support 3 (S3) 0.68 0.70 0.69
Support 4 (S4) 0.68